Study on clinicopathological features and prognosis of HER2 low expression breast cancer by RUAN Miao, DA Qian, XU Haimin, DONG Lei, FEI Xiaochun

Subjects: “…|breast cancer|immunohistochemistry|her2 low expression|clinicopathological features|prognosis…”
Get full text

Predictive factors for outcome in HER2-low breast cancer patients after neoadjuvant chemotherapy by Yingbo Shao, Yingbo Shao, Huijuan Guan, Huijuan Guan, Zhifen Luo, Zhifen Luo, Yang Yu, Yang Yu, Yaning He, Yaning He, Qi Chen, Qi Chen, Chaojun Liu, Chaojun Liu, Fangyuan Zhu, Fangyuan Zhu, Hui Liu, Hui Liu

Subjects: Get full text

Advances in research and current challenges in the treatment of advanced HER2-low breast cancer by Qiang Qin

Subjects: Get full text

Response and prognosis to neoadjuvant chemotherapy in women early breast cancer of HER2-low status by Yongtao Li, Tangnuer Buerliesi, Wenting Xu, Lina Yi, Fulati Wuwalihan

Subjects: Get full text

Clinical characteristics and therapeutic direction of HER2 low-expression breast cancer by Linlin Zhou, Yinghui Zhang, Jiayu Zhang, Hongyu Wang, Bozhi Zhao, Yixin Cai, Yuansong Qu, Xinxin Li, Dongwei Zhang

Subjects: “…HER2 low-expression breast cancer…”
Get full text

Case Report: Liver and bladder metastasis in a patient with HR-positive, HER2-low breast cancer by Lingting Jiang, Lingting Jiang, Yingkuan Shao, Qiang Chen, Sifeng Tao

Subjects: Get full text

Trastuzumab deruxtecan for the late lines of treatment for HER2-low metastatic breast cancer: a clinical case by R. A. Murashko, S. V. Sharov, E. P. Chashnikova

Subjects: “…breast cancer with her2-low expression…”
Get full text

Trastuzumab deruxtecan in the treatment of patients with advanced breast cancer with HER2-low expression: Recent studies review by I. V. Kolyadina

Subjects: “…breast cancer with her2-low expression…”
Get full text